- Home
- RNXT vs SRZN Comparison
RNXT vs SRZN Comparison
Compare RNXT & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- SRZN
- Stock Information
- Founded
- RNXT 2012
- SRZN 2015
- Country
- RNXT United States
- SRZN United States
- Employees
- RNXT N/A
- SRZN N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- RNXT Health Care
- SRZN Health Care
- Exchange
- RNXT Nasdaq
- SRZN Nasdaq
- Market Cap
- RNXT 31.6M
- SRZN 33.0M
- IPO Year
- RNXT 2021
- SRZN N/A
- Fundamental
- Price
- RNXT $1.03
- SRZN $11.20
- Analyst Decision
- RNXT Strong Buy
- SRZN Strong Buy
- Analyst Count
- RNXT 1
- SRZN 2
- Target Price
- RNXT $9.00
- SRZN $38.50
- AVG Volume (30 Days)
- RNXT 214.8K
- SRZN 27.9K
- Earning Date
- RNXT 03-31-2025
- SRZN 04-09-2025
- Dividend Yield
- RNXT N/A
- SRZN N/A
- EPS Growth
- RNXT N/A
- SRZN N/A
- EPS
- RNXT N/A
- SRZN N/A
- Revenue
- RNXT N/A
- SRZN $10,000,000.00
- Revenue This Year
- RNXT N/A
- SRZN N/A
- Revenue Next Year
- RNXT N/A
- SRZN N/A
- P/E Ratio
- RNXT N/A
- SRZN N/A
- Revenue Growth
- RNXT N/A
- SRZN N/A
- 52 Week Low
- RNXT $0.77
- SRZN $6.00
- 52 Week High
- RNXT $1.86
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- RNXT 35.37
- SRZN 49.20
- Support Level
- RNXT $1.00
- SRZN $11.25
- Resistance Level
- RNXT $1.18
- SRZN $12.55
- Average True Range (ATR)
- RNXT 0.10
- SRZN 0.97
- MACD
- RNXT -0.03
- SRZN 0.11
- Stochastic Oscillator
- RNXT 6.00
- SRZN 55.74
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).